FIG. 2.
Inhibition of G14, G15, and G19 binding by soluble serotype A and D GXMs. Binding by ELISA is shown. (A) Inhibition of the binding of the MAbs to 24067 by soluble SB4; (B) inhibition of the binding of the MAbs to 24067 by soluble 24067; (C) inhibition of the binding of the MAbs to H99 by soluble SB4. Binding is represented by the absorbance at 405 nm (Abs405) as shown on the y axis for the concentration of the indicated soluble GXM on the x axis. The curve representing G15 in panel A is not seen because it is the same as that of the control IgM.